Empire Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 8:43 pm

Competitors of Empire Industries Ltd

All Competitor Stocks of Empire Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 3:48 pm

Below is a detailed analysis of the quarterly data for Empire Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 166.80 Cr.. The value appears to be declining and may need further review. It has decreased from 186.39 Cr. (Mar 2025) to 166.80 Cr., marking a decrease of 19.59 Cr..
• For Expenses, as of Jun 2025, the value is 151.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 170.32 Cr. (Mar 2025) to 151.34 Cr., marking a decrease of 18.98 Cr..
• For Operating Profit, as of Jun 2025, the value is 15.46 Cr.. The value appears to be declining and may need further review. It has decreased from 16.07 Cr. (Mar 2025) to 15.46 Cr., marking a decrease of 0.61 Cr..
• For OPM %, as of Jun 2025, the value is 9.27%. The value appears strong and on an upward trend. It has increased from 8.62% (Mar 2025) to 9.27%, marking an increase of 0.65%.
• For Other Income, as of Jun 2025, the value is 3.37 Cr.. The value appears to be declining and may need further review. It has decreased from 3.44 Cr. (Mar 2025) to 3.37 Cr., marking a decrease of 0.07 Cr..
• For Interest, as of Jun 2025, the value is 4.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.91 Cr. (Mar 2025) to 4.69 Cr., marking a decrease of 3.22 Cr..
• For Depreciation, as of Jun 2025, the value is 3.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.10 Cr. (Mar 2025) to 3.83 Cr., marking a decrease of 1.27 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.31 Cr.. The value appears strong and on an upward trend. It has increased from 6.50 Cr. (Mar 2025) to 10.31 Cr., marking an increase of 3.81 Cr..
• For Tax %, as of Jun 2025, the value is 6.60%. The value appears to be improving (decreasing) as expected. It has decreased from 31.69% (Mar 2025) to 6.60%, marking a decrease of 25.09%.
• For Net Profit, as of Jun 2025, the value is 9.62 Cr.. The value appears strong and on an upward trend. It has increased from 4.44 Cr. (Mar 2025) to 9.62 Cr., marking an increase of 5.18 Cr..
• For EPS in Rs, as of Jun 2025, the value is 16.03. The value appears strong and on an upward trend. It has increased from 7.40 (Mar 2025) to 16.03, marking an increase of 8.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:25 am

Growth

Last Updated: September 5, 2025, 3:21 pm

Balance Sheet

Last Updated: September 10, 2025, 3:35 pm

Below is a detailed analysis of the balance sheet data for Empire Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2024) to 308.00 Cr., marking an increase of 14.00 Cr..
• For Borrowings, as of Mar 2025, the value is 150.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 168.00 Cr. (Mar 2024) to 150.00 Cr., marking a decrease of 18.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 286.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 256.00 Cr. (Mar 2024) to 286.00 Cr., marking an increase of 30.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 751.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 724.00 Cr. (Mar 2024) to 751.00 Cr., marking an increase of 27.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 304.00 Cr.. The value appears to be declining and may need further review. It has decreased from 315.00 Cr. (Mar 2024) to 304.00 Cr., marking a decrease of 11.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Mar 2024) to 11.00 Cr., marking a decrease of 18.00 Cr..
• For Other Assets, as of Mar 2025, the value is 435.00 Cr.. The value appears strong and on an upward trend. It has increased from 380.00 Cr. (Mar 2024) to 435.00 Cr., marking an increase of 55.00 Cr..
• For Total Assets, as of Mar 2025, the value is 751.00 Cr.. The value appears strong and on an upward trend. It has increased from 724.00 Cr. (Mar 2024) to 751.00 Cr., marking an increase of 27.00 Cr..

Notably, the Reserves (308.00 Cr.) exceed the Borrowings (150.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Empire Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 57.42. This value is within the healthy range. It has decreased from 61.67 (Mar 24) to 57.42, marking a decrease of 4.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 57.42. This value is within the healthy range. It has decreased from 61.67 (Mar 24) to 57.42, marking a decrease of 4.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 86.16. This value is within the healthy range. It has decreased from 89.12 (Mar 24) to 86.16, marking a decrease of 2.96.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 523.43. It has increased from 500.36 (Mar 24) to 523.43, marking an increase of 23.07.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 523.43. It has increased from 500.36 (Mar 24) to 523.43, marking an increase of 23.07.
• For Dividend / Share (Rs.), as of Mar 25, the value is 25.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 25.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,128.28. It has increased from 1,010.03 (Mar 24) to 1,128.28, marking an increase of 118.25.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 140.87. This value is within the healthy range. It has decreased from 148.19 (Mar 24) to 140.87, marking a decrease of 7.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 112.13. This value is within the healthy range. It has decreased from 120.75 (Mar 24) to 112.13, marking a decrease of 8.62.
• For PBT / Share (Rs.), as of Mar 25, the value is 66.68. This value is within the healthy range. It has decreased from 76.11 (Mar 24) to 66.68, marking a decrease of 9.43.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 57.42. This value is within the healthy range. It has decreased from 61.67 (Mar 24) to 57.42, marking a decrease of 4.25.
• For PBDIT Margin (%), as of Mar 25, the value is 12.48. This value is within the healthy range. It has decreased from 14.67 (Mar 24) to 12.48, marking a decrease of 2.19.
• For PBIT Margin (%), as of Mar 25, the value is 9.93. This value is below the healthy minimum of 10. It has decreased from 11.95 (Mar 24) to 9.93, marking a decrease of 2.02.
• For PBT Margin (%), as of Mar 25, the value is 5.90. This value is below the healthy minimum of 10. It has decreased from 7.53 (Mar 24) to 5.90, marking a decrease of 1.63.
• For Net Profit Margin (%), as of Mar 25, the value is 5.08. This value is within the healthy range. It has decreased from 6.10 (Mar 24) to 5.08, marking a decrease of 1.02.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.96. This value is below the healthy minimum of 15. It has decreased from 12.32 (Mar 24) to 10.96, marking a decrease of 1.36.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.74. This value is within the healthy range. It has decreased from 15.19 (Mar 24) to 12.74, marking a decrease of 2.45.
• For Return On Assets (%), as of Mar 25, the value is 4.58. This value is below the healthy minimum of 5. It has decreased from 5.08 (Mar 24) to 4.58, marking a decrease of 0.50.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.21, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.45. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has increased from 0.82 (Mar 24) to 0.91, marking an increase of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 1.75, marking an increase of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 1.31. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.31, marking an increase of 0.27.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.69. This value is within the healthy range. It has increased from 0.75 (Mar 24) to 6.69, marking an increase of 5.94.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.54. This value is within the healthy range. It has increased from 40.53 (Mar 24) to 43.54, marking an increase of 3.01.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 29.01. This value is within the healthy range. It has increased from 28.05 (Mar 24) to 29.01, marking an increase of 0.96.
• For Earning Retention Ratio (%), as of Mar 25, the value is 56.46. This value is within the healthy range. It has decreased from 59.47 (Mar 24) to 56.46, marking a decrease of 3.01.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 70.99. This value exceeds the healthy maximum of 70. It has decreased from 71.95 (Mar 24) to 70.99, marking a decrease of 0.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.10. This value is within the healthy range. It has decreased from 3.32 (Mar 24) to 3.10, marking a decrease of 0.22.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 2.26, marking a decrease of 0.12.
• For Enterprise Value (Cr.), as of Mar 25, the value is 639.10. It has increased from 615.47 (Mar 24) to 639.10, marking an increase of 23.63.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.94, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 7.56. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 7.56, marking an increase of 0.64.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.88 (Mar 24) to 0.92, marking an increase of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 56.45. This value is within the healthy range. It has decreased from 59.46 (Mar 24) to 56.45, marking a decrease of 3.01.
• For Price / BV (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 2.00, marking an increase of 0.22.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.88 (Mar 24) to 0.92, marking an increase of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness